These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8673713)

  • 21. Contrast agents and temporal resolution in breast MR imaging.
    Sardanelli F; Iozzelli A; Fausto A
    J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):69-75. PubMed ID: 12585658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization and molecular detection of atherothrombosis by magnetic resonance--potential tools for individual risk assessment and diagnostics.
    Ala-Korpela M; Sipola P; Kaski K
    Ann Med; 2006; 38(5):322-36. PubMed ID: 16938802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular MR imaging of human thrombi in a swine model of pulmonary embolism using a fibrin-specific contrast agent.
    Spuentrup E; Katoh M; Buecker A; Fausten B; Wiethoff AJ; Wildberger JE; Haage P; Parsons EC; Botnar RM; Graham PB; Vettelschoss M; Günther RW
    Invest Radiol; 2007 Aug; 42(8):586-95. PubMed ID: 17620942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Environment-sensitive and enzyme-sensitive MR contrast agents.
    Querol M; Bogdanov A
    Handb Exp Pharmacol; 2008; (185 Pt 2):37-57. PubMed ID: 18626598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current uses of gadolinium chelates for clinical magnetic resonance imaging examination of the liver.
    Low RN
    Top Magn Reson Imaging; 1998 Jun; 9(3):141-66. PubMed ID: 9621404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
    Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
    Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imaging of inflammation in the peripheral and central nervous system by magnetic resonance imaging.
    Stoll G; Bendszus M
    Neuroscience; 2009 Feb; 158(3):1151-60. PubMed ID: 18651996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Applications of manganese-enhanced magnetic resonance imaging (MEMRI) to imaging of the heart.
    Wendland MF
    NMR Biomed; 2004 Dec; 17(8):581-94. PubMed ID: 15761947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contrast agents for cerebral perfusion MR imaging.
    Unger EC; Ugurbil K; Latchaw RE
    J Magn Reson Imaging; 1994; 4(3):235-42. PubMed ID: 8061420
    [No Abstract]   [Full Text] [Related]  

  • 30. Receptor-directed contrast agents for MR imaging: preclinical evaluation with affinity assays.
    Reimer P; Weissleder R; Wittenberg J; Brady TJ
    Radiology; 1992 Feb; 182(2):565-9. PubMed ID: 1732982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional hyperbranched polymers: toward targeted in vivo 19F magnetic resonance imaging using designed macromolecules.
    Thurecht KJ; Blakey I; Peng H; Squires O; Hsu S; Alexander C; Whittaker AK
    J Am Chem Soc; 2010 Apr; 132(15):5336-7. PubMed ID: 20345132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Contrast agents in MRT. Substance, effects, pharmacology and validity].
    Reimer P; Vosshenrich R
    Radiologe; 2004 Mar; 44(3):273-83. PubMed ID: 15287365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnetic resonance contrast media sensing in vivo molecular imaging agents: an overview.
    Amanlou M; Siadat SD; Norouzian D; Ebrahimi SE; Aghasadeghi MR; Ghorbani M; Alavidjeh MS; Inanlou DN; Arabzadeh AJ; Ardestani MS
    Curr Radiopharm; 2011 Jan; 4(1):31-43. PubMed ID: 22191613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tissue-specific MR contrast agents.
    Weinmann HJ; Ebert W; Misselwitz B; Schmitt-Willich H
    Eur J Radiol; 2003 Apr; 46(1):33-44. PubMed ID: 12648800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contrast Agents for MR Imaging.
    Czeyda-Pommersheim F; Martin DR; Costello JR; Kalb B
    Magn Reson Imaging Clin N Am; 2017 Nov; 25(4):705-711. PubMed ID: 28964460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Status of liposomes as MR contrast agents.
    Unger EC; Shen DK; Fritz TA
    J Magn Reson Imaging; 1993; 3(1):195-8. PubMed ID: 8428087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chelates of gadolinium and dysprosium as contrast agents for MR imaging.
    Rocklage SM; Watson AD
    J Magn Reson Imaging; 1993; 3(1):167-78. PubMed ID: 8428084
    [No Abstract]   [Full Text] [Related]  

  • 38. Applications of hyperpolarized agents in solutions.
    Ardenkjaer-Larsen JH; Jóhannesson H; Petersson JS; Wolber J
    Methods Mol Biol; 2011; 771():655-89. PubMed ID: 21874502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Water-soluble polysaccharides as carriers of paramagnetic contrast agents for magnetic resonance imaging: synthesis and relaxation properties.
    Rongved P; Klaveness J
    Carbohydr Res; 1991 Jul; 214(2):315-23. PubMed ID: 1769023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ferrite particles as an MR contrast agent.
    Saini S; Ferrucci JT
    Radiology; 1988 Dec; 169(3):656. PubMed ID: 3186987
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.